Viquipèdia

Llista d'autoritzacions de vaccins contra la COVID-19: diferència entre les revisions

Exploració interactiva de l'historial
← Edició anteriorEdició següent →
Contingut suprimit Contingut afegit
VisualWikitext
Robot estandarditza i catalanitza referències, catalanitza dates i fa altres canvis menors
Línia 187:
|TD=limegreen
|TG=limegreen
|TH=dodgerblue
|TJ=limegreen
|TL=limegreen
Linha 216 ⟶ 217:
{{leftlegend|limegreen|Destinatari apte per a [[COVAX]]}}
 
;Plena (7+27=<section begin="Pfizer-BioNTech_FN"/>345<section end="Pfizer-BioNTech_FN"/>)
<div style="margin-top: 0.3em; column-width: 20em;">
# [[Aràbia Saudí]]<ref>{{ref-web|data=10 desembre 2020|títol=Coronavirus: Saudi Arabia approves Pfizer COVID-19 vaccine for use|url=https://english.alarabiya.net/en/coronavirus/2020/12/10/Coronavirus-Saudi-Arabia-approves-Pfizer-COVID-19-vaccine-for-use|access-date=10 desembre 2020|website=Al Arabiya English}}</ref><ref>{{ref-notícia|cognom1=Zimmer|nom1=Carl|cognom2=Corum|nom2=Jonathan|cognom3=Wee|nom3=Sui-Lee|data=2020-06-10|títol=Coronavirus Vaccine Tracker|obra=The New York Times|url=https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html|access-date=12 desembre 2020|issn=0362-4331}}</ref>
# [[Brasil]]<ref name="Brazil approves full vaccine">{{ref-web|url=https://g1.globo.com/bemestar/vacina/noticia/2021/02/23/anvisa-concede-registro-definitivo-a-vacina-da-pfizer.ghtml|títol=Vacina da Pfizer é a 1ª a obter registro definitivo no Brasil|editor=G1|data= 23 febrer 2021|access-date= 23 febrer 2021|llengua=pt-br}}</ref>
# [[Islàndia]]<ref name="Iceland">{{ref-web|url=https://www.covid.is/vaccine-agreements|títol=An overview of vaccine contracts for Iceland |website=Directorate of Health|access-date= 20 març 2021}}</ref>
# [[Liechtenstein]]<ref name="Comirnaty EPAR">{{ref-web|títol=Comirnaty EPAR|url=https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty|access-date=23 desembre 2020|website=[[European Medicines Agency]] (EMA)}}</ref><ref name="EU Marketing authorisation" /><ref name="EU CMA QandA" />
# [[Noruega]]<ref name="Comirnaty EPAR" /><ref name="EU Marketing authorisation" /><ref name="EU CMA QandA" />
# [[Nova Zelanda]]<ref>{{ref-web|data= 3 febrer 2021|títol=Robust assessment ahead of Medsafe approval of vaccine|url=https://www.health.govt.nz/news-media/media-releases/robust-assessment-ahead-medsafe-approval-vaccine|access-date= 6 febrer 2021|obra=Ministry of Health}}</ref>
# [[Suïssa]]<ref name="Swiss authorization">{{cite press release|title=Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland|url=https://www.bag.admin.ch/bag/en/home/das-bag/aktuell/medienmitteilungen.msg-id-81761.html|publisher=[[Swissmedic|Swiss Agency for Therapeutic Products (Swissmedic)]]|date=19 desembre 2020|access-date=19 desembre 2020}}</ref><ref>{{ref-web|títol=Comirnaty Product information|url=https://www.swissmedicinfo.ch/ShowText.aspx?textType=FI&lang=DE&authNr=68225|access-date= 31 gener 2021|llengua=DE|trans-quote=Due to incomplete clinical data at the time of the assessment of the authorization application, the Comirnaty medicinal product is authorized for a limited period (Art. 9a Medicinal Products Act).}}</ref>
# [[Unió Europea]]<ref name="EU PR 20201221">{{ref-publicació | títol=EMA recommends first COVID-19 vaccine for authorisation in the EU | publicació=[[European Medicines Agency]] (EMA) | data= 21 desembre 2020 | url=https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu | llengua=anglès |consulta= 27 desembre 2020}}</ref><ref name="eu vac">{{ref-web|url=https://ec.europa.eu/commission/presscorner/detail/en/qanda_20_2467 |títol=Questions and Answers: COVID-19 vaccination in the EU |data=21 desembre 2020 |website=[[European Commission]] |access-date=21 desembre 2020}}</ref>
</div>
 
;Emergència (4749+24+27=<section begin="Pfizer-BioNTech_EN"/>71100<section end="Pfizer-BioNTech_EN"/>)
<div style="margin-top: 0.3em; column-width: 20em;">
# [[Albània]]<ref>{{ref-web|url=https://seenews.com/news/albania-to-start-covid-19-immunisation-with-pfizer-vaccine-in-jan-report-726470|títol=Albania to start COVID-19 immunisation with Pfizer vaccine in Jan - report|website=Seenews}}</ref>
# [[Andorra]]<ref>{{ref-web|url=https://www.govern.ad/covid19_newsletter/en/|títol=ANDORRA COVID-19|website=govern.ad|access-date= 19 febrer 2021}}</ref>
# [[Argentina]]<ref>{{ref-web|url=https://www.lanacion.com.ar/sociedad/coronavirus-argentina-anmat-aprobo-uso-emergencia-vacuna-nid2548852|títol=Coronavirus en la Argentina: La ANMAT aprobo el uso de emergencia de la vacuna Pfizer|access-date=2020-12-23|website=La Nación|llengua=es}}</ref>
# [[Aruba]]<ref name="auto">{{ref-web|url=https://www.government.aw/news/news_47033/item/covid-19-vaccine-update_55561.html|títol=COVID-19 vaccine update|nom=Aruba|cognom=Overheid|data=Jan 7, 2021|website=www.government.aw|access-date=Feb 19, 2021}}</ref>
# [[Austràlia]]<ref>{{ref-web|títol=Comirnaty|url=https://www.tga.gov.au/apm-summary/comirnaty|data= 25 gener 2021|access-date= 25 gener 2021|website=Therapeutic Goods Administration}}</ref>
# [[Bahrain]]<ref>{{ref-web|títol=Bahrain becomes second country to approve Pfizer COVID-19 vaccine|url=https://www.aljazeera.com/news/2020/12/4/bahrain-becomes-second-country-to-approve-pfizer-covid-19-vaccine|access-date=5 desembre 2020|editor=[[Al Jazeera]]}}</ref>
# [[Botswana]]<ref>{{ref-web|títol=Botswana expects to welcome multiple COVID-19 vaccines |url=http://www.xinhuanet.com/english/africa/2021-02/27/c_139771113.htm|access-date=2021-04-01|website=Xinhua}}</ref>
# [[Brunei]]<ref>{{ref-web|títol=COVID-19: Brunei to begin mass vaccination on April 3 |url=https://thescoop.co/2021/04/02/covid-19-brunei-to-begin-mass-vaccination-on-april-3/|access-date=2021-04-06|website=TheScoop}}</ref>
Linha 251 ⟶ 246:
# [[Illes Faroe]]<ref>{{ref-web|cognom=Nielsdóttir|nom=Alda|data=2020-12-30|títol=First Covid-19 vaccines administered in the Faroe Islands|url=https://local.fo/first-covid-19-vaccines-administered-in-the-faroe-islands/|url-status=live|access-date=2021-03-29|website=Local.fo}}</ref>
# [[Iraq]]<ref>{{ref-web|títol=Iraq grants emergency approval for Pfizer COVID-19 vaccine|url=https://www.msn.com/en-ae/news/other/iraq-grants-emergency-approval-for-pfizer-covid-19-vaccine/ar-BB1cgvD6|access-date=2020-12-27|website=www.msn.com}}</ref>
# [[Islàndia]]{{efn|name=viaEMA}}
# [[Israel]]<ref>{{ref-web|títol=Israeli Health Minister ‘pleased’ as FDA approves Pfizer COVID-19 vaccine|url=https://www.jpost.com/breaking-news/fda-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use-nyt-651871|access-date=2020-12-28|website=The Jerusalem Post {{!}} JPost.com|llengua=en-US}}</ref>
# [[Japó]]<ref>{{ref-notícia|data= 14 febrer 2021|títol=Japan approves Pfizer's COVID-19 vaccine, 1st for domestic use|obra=[[Nikkei Asia]]|url=https://asia.nikkei.com/Spotlight/Coronavirus/Japan-approves-Pfizer-s-COVID-19-vaccine-1st-for-domestic-use|access-date= 14 febrer 2021|name-list-style=vanc}}</ref><ref>{{ref-web|cognom=Tsukimori|nom=Osamu|data=2021-02-15|títol=Japan gives OK to Pfizer coronavirus vaccine, with rollout to begin this week|url=https://www.japantimes.co.jp/news/2021/02/15/national/science-health/pfizer-vaccine-approval-japan/|access-date=2021-04-01|website=The Japan Times}}</ref>
Linha 256 ⟶ 252:
# [[Kuwait]]<ref>{{ref-web|consulta=15 desembre 2020|títol=Kuwait authorizes emergency use of Pfizer-BioNTech COVID-19 vaccine|url=https://arab.news/427j9|data=13 desembre 2020|website=Arab News}}</ref>
# [[Líban]]<ref>{{ref-web|títol=Lebanon starts Covid-19 vaccination campaign |url=https://www.france24.com/en/middle-east/20210214-lebanon-starts-covid-19-vaccination-campaign |website=France 24 |access-date= 16 març 2021 |llengua=en |data= 14 febrer 2021}}</ref>
# [[Liechtenstein]]{{efn|name=viaEMA}}
# [[Macedònia del Nord]]<ref>https://www.rferl.org/a/north-macedonia-kicks-off-covid-19-vaccinations/31108206.html</ref>
# [[Malàisia]]<ref>{{ref-notícia|cognom=Lim|nom=Ida|data= 8 gener 2021|títol=Khairy: Malaysia can use Pfizer's Covid-19 vaccine now as conditional registration granted|obra=[[The Malay Mail]]|url=https://www.msn.com/en-my/news/national/khairy-malaysia-can-use-pfizer-e2-80-99s-covid-19-vaccine-now-as-conditional-registration-granted/ar-BB1czVUU|access-date= 8 gener 2021|name-list-style=vanc}}</ref>
Linha 263 ⟶ 260:
# [[Mònaco]]<ref>{{ref-web|títol=FIRST VACCINES ARRIVE IN MONACO – COVID-19 vaccination campaign begins tomorrow / Actualités / Coronavirus (Covid-19) / Policy & Practice / Portail du Gouvernement – Monaco|url=https://en.gouv.mc/Policy-Practice/Coronavirus-Covid-19/Actualites/FIRST-VACCINES-ARRIVE-IN-MONACO-COVID-19-vaccination-campaign-begins-tomorrow|access-date= 19 febrer 2021|website=en.gouv.mc}}</ref>
# [[Mongòlia]]<ref>{{ref-web|títol=Mongolia will receive 300,000 doses of COVID-19 vaccine developed by China|url=https://akipress.com/news:654794:Mongolia_will_receive_300,000_doses_of_COVID-19_vaccine_developed_by_China/|access-date=2021-03-19|website=akipress.com}}</ref>
# [[Noruega]]{{efn|name=viaEMA}}
# [[Oman]]<ref name="oman">{{ref-notícia|data=15 desembre 2020|títol=Oman issues licence to import Pfizer BioNTech Covid vaccine – TV|editorial=Reuters|url=https://www.reuters.com/article/health-coronavirus-oman-vaccine-int-idUSKBN28P1RA|access-date=16 desembre 2020}}</ref>
# [[OMS]]<ref name="WHO status">{{ref-web| url=https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_16Feb2021.pdf |títol=Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process |editor=[[World Health Organization]] (WHO)}}</ref><ref>{{cite press release | title=WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access | website=[[World Health Organization]] (WHO) | url=https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access | date=31 desembre 2020 | access-date= 6 gener 2021}}</ref>
Linha 273 ⟶ 271:
# [[Sud-Àfrica]]<ref>{{ref-web|títol=South Africa approves Pfizer Covid-19 vaccine for emergency use|url=https://businesstech.co.za/news/trending/476360/south-africa-approves-pfizer-covid-19-vaccine-for-emergency-use/|access-date=2021-03-19}}</ref><ref>{{ref-web|cognom=https://www.timeslive.co.za/authors/unathi-nkanjeni|títol=Pfizer-BioNTec approved for emergency use in SA: here is what you need to know about the vaccine|url=https://www.timeslive.co.za/news/south-africa/2021-03-18-pfizer-biontec-approved-for-emergency-use-in-sa-here-is-what-you-need-to-know-about-the-vaccine/|access-date=2021-03-19|website=TimesLIVE}}</ref>
# [[Surinam]]<ref>{{ref-notícia|cognom=Staff|nom=Reuters|data=2021-02-23|títol=Suriname begins coronavirus vaccination campaign with donated dosis|llengua=en|obra=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-suriname-vaccine-idUSKBN2AN2AT|access-date=2021-02-28}}</ref>
# [[Tailàndia]]<ref>{{cite web |title=Thailand reduces quarantine, paperwork for vaccinated |url=https://apnews.com/article/thailand-asia-pacific-coronavirus-pandemic-coronavirus-vaccine-b6abe7ede141b33a3a19ab7bb219fa12 |website=AP NEWS |access-date=7 April 2021 |date=1 April 2021}}</ref>
# [[Tunísia]]<ref name=":1">{{ref-notícia|cognom=Zimmer|nom=Carl|cognom2=Corum|nom2=Jonathan|cognom3=Wee|nom3=Sui-Lee|títol=Coronavirus Vaccine Tracker|obra=The New York Times|url=https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html|access-date=2021-04-01|issn=0362-4331}}</ref>
# [[Turquia]]<ref>{{ref-web|autor=Gözde Bayar |data=2021-03-18 |url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkey-to-receive-45m-doses-of-pfizer-vaccine-this-month/2179702 |títol=Turkey to receive 4.5M doses of Pfizer vaccine this month |obra=Anadolu Agency}}</ref>
# [[Ucraïna]]<ref>{{ref-web|títol=Наказ МОЗ України від 22.02.2021 № 308 "Про державну реєстрацію лікарського засобу (медичного імунобіологічного препарату) для екстреного медичного застосування"|url=https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-22022021--308-pro-derzhavnu-reestraciju-likarskogo-zasobu-medichnogo-imunobiologichnogo-preparatu-dlja-ekstrenogo-medichnogo-zastosuvannja|access-date= 19 març 2021|website=moz.gov.ua}}</ref>
# [[Unió Europea]]{{efn|name=viaEMA|Via autorització [[Agència Europea del Medicament]] <ref name="Comirnaty EPAR" /><ref name="EU Marketing authorisation">{{cite web | title=Marketing authorisation | website=European Medicines Agency | url=https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation | access-date=23 March 2021}}</ref><ref name="EU CMA QandA">{{cite press release | title=Questions and Answers: Conditional Marketing Authorisation of COVID-19 Vaccines in the EU | website=European | url=https://ec.europa.eu/commission/presscorner/home/en | access-date=1 April 2021}}</ref><ref name="Vaxzevria EPAR" /><ref name="COVID-19 Vaccine Janssen EPAR" /><ref name="COVID-19 Vaccine Moderna EPAR">{{cite web | title=COVID-19 Vaccine Moderna EPAR | website=[[European Medicines Agency]] (EMA) | url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-moderna | access-date=20 January 2021}}</ref>}}
# [[Ciutat del Vaticà]]<ref>{{ref-notícia|url=https://www.ncronline.org/news/coronavirus/vatican-offer-coronavirus-vaccine-residents-and-staff-early-2021|títol=Vatican to offer coronavirus vaccine to residents and staff in early 2021|data= 11 desembre 2020|access-date= 9 febrer 2021|nom=Joshua J.|cognom=McElwee|editorial=[[National Catholic Reporter]]}}</ref><ref>{{cite press release|url=https://www.vaticannews.va/it/vaticano/news/2020-12/in-vaticano-parte-il-piano-vaccinale-anticovid.html|title=In Vaticano parte il piano vaccinale anticovid|date= 11 desembre 2020|access-date= 9 febrer 2021|first=Massimiliano|last=Menichetti|website=vatican.va}}</ref>
# [[Xile]]<ref name="chile">{{ref-web|access-date=2020-12-17|títol=Chile approves Pfizer-BioNTech Covid-19 vaccine for emergency use|url=https://www.straitstimes.com/world/chile-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use|data=17 desembre 2020|website=The Straits Times}}</ref>
Obtingut de «https://ca.wikipedia.org/wiki/Llista_d%27autoritzacions_de_vaccins_contra_la_COVID-19»